Rates and Determinants of Depression and Anxiety Among Acute Leukemia Patients
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Data Collection
2.3. Demographic and Clinical Variables
2.4. Anxiety Assessment
2.5. Depression Assessment
2.6. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Shimony, S.; Stahl, M.; Stone, R.M. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am. J. Hematol. 2023, 98, 502–526. [Google Scholar] [CrossRef] [PubMed]
- Oliva, E.N.; Ronnebaum, S.M.; Zaidi, O.; Patel, D.A.; Nehme, S.A.; Chen, C.; Almeida, A.M. A systematic literature review of disease burden and clinical efficacy for patients with relapsed or refractory acute myeloid leukemia. Am. J. Blood Res. 2021, 11, 325–360. [Google Scholar] [PubMed]
- Chen, J.; Pang, W.; Deng, M.; Zheng, R.; Chen, Y.; Zhang, Z.; Tan, Z.; Bai, Z. Global, regional, and national burden of leukemia, 1990–2021: A systematic analysis of the global burden of disease in 2021. Front. Med. 2025, 12, 1542317. [Google Scholar] [CrossRef]
- Chen, P.; Liu, X.; Zhao, Y.; Hu, Y.; Guo, J.; Wang, H. Global, national, and regional burden of acute myeloid leukemia among 60-89 years-old individuals: Insights from a study covering the period 1990 to 2019. Front. Public Health 2023, 11, 1329529. [Google Scholar] [CrossRef]
- Divya, D.; Dhruvkumar, G.; Fnu, S.; Nupur, S.; Mohit, L.; Saifullah, S.; Adit Alpesh, D.; Dharmik, P.; Vishrant, A.; Juhi, P.; et al. Epidemiological Trends of Acute Lymphoid Leukemia in Individuals Younger Than 20 Years across 204 Countries and Territories from 1990–2021: A Benchmarking Global Analysis. Blood 2024, 144 (Suppl. 1), 1428. [Google Scholar] [CrossRef]
- Thao, L.T.T.; Ha, C.T.; Ha, N.T.T.; Beaupha, S.M.C.; Nghia, H.; Tung, T.T.; Son, N.T.; Binh, N.T.; Dung, P.C.; Vu, H.A.; et al. Cytogenetic Characteristics of de novo Acute Myeloid Leukemia in Southern Vietnam. Asian Pac. J. Cancer Prev. 2023, 24, 1789–1795. [Google Scholar] [CrossRef]
- Rubnitz, J.E.; Inaba, H.; Dahl, G.; Ribeiro, R.C.; Bowman, W.P.; Taub, J.; Pounds, S.; Razzouk, B.I.; Lacayo, N.J.; Cao, X.; et al. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: Results of the AML02 multicentre trial. Lancet Oncol. 2010, 11, 543–552. [Google Scholar] [CrossRef]
- Leak Bryant, A.; Walton, A.L.; Pergolotti, M.; Phillips, B.; Bailey, C.; Mayer, D.K.; Battaglini, C. Perceived Benefits and Barriers to Exercise for Recently Treated Adults With Acute Leukemia. Oncol. Nurs. Forum. 2017, 44, 413–420. [Google Scholar] [CrossRef]
- Meng, Q.; Yang, Z.; Wu, Y.; Xiao, Y.; Gu, X.; Zhang, M.; Wan, C.; Li, X. Reliability analysis of the Chinese version of the Functional Assessment of Cancer Therapy—Leukemia (FACT-Leu) scale based on multivariate generalizability theory. Health Qual. Life Outcomes 2017, 15, 93. [Google Scholar] [CrossRef]
- Albrecht, T.A. Physiologic and psychological symptoms experienced by adults with acute leukemia: An integrative literature review. Oncol. Nurs. Forum. 2014, 41, 286–295. [Google Scholar] [CrossRef]
- Gheihman, G.; Zimmermann, C.; Deckert, A.; Fitzgerald, P.; Mischitelle, A.; Rydall, A.; Schimmer, A.; Gagliese, L.; Lo, C.; Rodin, G. Depression and hopelessness in patients with acute leukemia: The psychological impact of an acute and life-threatening disorder. Psycho-Oncology 2016, 25, 979–989. [Google Scholar] [CrossRef] [PubMed]
- Gu, M.; Hao, X.; Cong, L.; Sun, J. The prevalence, risk factors, and prognostic value of anxiety and depression in refractory or relapsed acute myeloid leukemia patients of North China. Medicine 2019, 98, e18196. [Google Scholar] [CrossRef]
- Tao, Z.; Dan, X.; Wenchao, L. Prevalence, risk factors, and prognostic value of anxiety and depression in acute myeloid leukemia. Acta Haematol. 2024, 147, 576–586. [Google Scholar] [CrossRef]
- Mehmet Hilmi, D.; Rafet, E.; Ebru, Y.; Nihan, N.; Ceyda, A.; Osman, Y.; Elif, S.; Habip, G. Are We Aware of Anxiety and Depression in Patients with Newly Diagnosed Acute Leukemia. J. Gen. Pract. 2017, 5, 1–4. [Google Scholar] [CrossRef]
- Elba Nelly, C.-V.; Ángeles Abigail, G.-G.; Polette Alejandra, S.-F.; Luis Eduardo, G.-C.; Daniel Alejandro, O.-F.; Irma Beatriz, G.-M.; Máximo Alejandro, G.-F.; Socorro, M.-M. Depression, anxiety and quality of life in pediatric patients with leukemia. Rev. Medica Inst. Mex. Seguro Soc. 2022, 60, 517–523. [Google Scholar]
- Thomas, B. Psychological Distress in Young Adults with Acute Myeloid Leukemia Undergoing Induction Chemotherapy. J. Adolesc. Young Adult Oncol. 2022, 136, 17–18. [Google Scholar] [CrossRef]
- Colleoni, M.; Mandala, M.; Peruzzotti, G.; Robertson, C.; Bredart, A.; Goldhirsch, A. Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet 2000, 356, 1326–1327. [Google Scholar] [CrossRef]
- Katon, W.J. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol. Psychiatry 2003, 54, 216–226. [Google Scholar] [CrossRef] [PubMed]
- Leung, D.; Esplen, M.J.; Peter, E.; Howell, D.; Rodin, G.; Fitch, M. How haematological cancer nurses experience the threat of patients’ mortality. J. Adv. Nurs. 2012, 68, 2175–2184. [Google Scholar] [CrossRef]
- Rodin, G.; Yuen, D.; Mischitelle, A.; Minden, M.D.; Brandwein, J.; Schimmer, A.; Marmar, C.; Gagliese, L.; Lo, C.; Rydall, A.; et al. Traumatic stress in acute leukemia. Psycho-Oncology 2013, 22, 299–307. [Google Scholar] [CrossRef]
- Brown, P.A.; Shah, B.; Advani, A.; Aoun, P.; Boyer, M.W.; Burke, P.W.; DeAngelo, D.J.; Dinner, S.; Fathi, A.T.; Gauthier, J.; et al. Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc. Netw. 2021, 19, 1079–1109. [Google Scholar] [CrossRef] [PubMed]
- Zung, W.W. A rating instrument for anxiety disorders. Psychosomatics 1971, 12, 371–379. [Google Scholar] [CrossRef] [PubMed]
- Zung, W.W. How Normal Is Anxiety? Upjohn Company: Portage, MI, USA, 1980. [Google Scholar]
- Beck, A.T.; Ward, C.H.; Mendelson, M.; Mock, J.; Erbaugh, J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4, 561–571. [Google Scholar] [CrossRef]
- Zhou, F.; Zhang, W.; Wei, Y.; Zhou, D.; Su, Z.; Meng, X.; Hui, L.; Tian, W. The changes of oxidative stress and human 8-hydroxyguanine glycosylase1 gene expression in depressive patients with acute leukemia. Leuk. Res. 2007, 31, 387–393. [Google Scholar] [CrossRef]
- Aili, K.; Arvidsson, S.; Nygren, J.M. Health related quality of life and buffering factors in adult survivors of acute pediatric lymphoblastic leukemia and their siblings. Health Qual. Life Outcomes 2021, 19, 55. [Google Scholar] [CrossRef]
- Lennmyr, E.B.; Karlsson, K.; Abrahamsson, M.; Ebrahim, F.; Lübking, A.; Höglund, M.; Juliusson, G.; Hallböök, H. Introducing patient-reported outcome in the acute leukemia quality registries in Sweden. Eur. J. Haematol. 2020, 104, 571–580. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.; Yan, J.; Chen, J.; Wang, C.; Lin, Y.; Wu, Y.; Hu, R. Comparison of the anxiety, depression and their relationship to quality of life among adult acute leukemia patients and their family caregivers: A cross-sectional study in China. Qual. Life Res. 2021, 30, 1891–1901. [Google Scholar] [CrossRef]
- Rodin, G.; Deckert, A.; Tong, E.; Le, L.W.; Rydall, A.; Schimmer, A.; Marmar, C.R.; Lo, C.; Zimmermann, C. Traumatic stress in patients with acute leukemia: A prospective cohort study. Psycho-Oncology 2018, 27, 515–523. [Google Scholar] [CrossRef]
- Janda, M.; Neale, R.E.; Klein, K.; O’Connell, D.L.; Gooden, H.; Goldstein, D.; Merrett, N.D.; Wyld, D.K.; Rowlands, I.J.; Beesley, V.L. Anxiety, depression and quality of life in people with pancreatic cancer and their carers. Pancreatology 2017, 17, 321–327. [Google Scholar] [CrossRef]
- Mohamed, A.-E.; Nada, K.A.; Gehad, T.G.; Madeeh, A.K.; Moaz, K.; Mahmoud, R.; Wessam, H.H.; Eman, A.A.; Marwa Gamal, M.; Ahmed, A.; et al. Prevalence of depression and anxiety among diabetic patients in Egypt: A cross-sectional study. Medicine 2023, 102, e35988. [Google Scholar] [CrossRef]
- Kasturi, H.; Ali, M.F.; Saurabh, A.; Sanjay Kumar, V.; Vipul, R.S. Assessment of depression, anxiety and stress among patients with type II diabetes mellitus attending a tertiary care centre. Int. J. Adv. Med. 2023, 10, 523–526. [Google Scholar] [CrossRef]
- Yongguang, L.; Jue, C.; Junxia, W.; Min, T.; Jingyi, G.; Jingyu, H.; Qing, Z.; Gang, Z.; Xiaoli, H.; Beibei, H. The Degree of Anxiety and Depression in Patients With Cardiovascular Diseases as Assessed Using a Mobile App: Cross-Sectional Study. J. Med. Internet Res. 2023, 25, e48750. [Google Scholar] [CrossRef]
- Tihitina, S.; Missaye, M.; Tewodrose, H.; Tafere Mulaw, B. The prevalence of depression and anxiety among cardiovascular patients at University of Gondar specialized hospital using beck’s depression inventory II and beck anxiety inventory: A cross-sectional study. Heliyon 2024, 10, e24079. [Google Scholar] [CrossRef]
- Karl, P.; Supa, P. Anxiety and depressive features in chronic disease patients in Cambodia, Myanmar and Vietnam. South Afr. Med. J. 2016, 22, 940. [Google Scholar] [CrossRef]
- Ivana, B.; Erik, R.S.; Erik, R.S.; Erik, R.S.; Hege, S.; Ottar, B.; Ottar, B. Prevalence trends of depression and anxiety symptoms in adults with cardiovascular diseases and diabetes 1995–2019: The HUNT studies, Norway. BMC Psychol. 2021, 9, 130. [Google Scholar] [CrossRef]
- Linden, W.; Vodermaier, A.; Mackenzie, R.; Greig, D. Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age. J. Affect. Disord. 2012, 141, 343–351. [Google Scholar] [CrossRef] [PubMed]
- Hinz, A.; Herzberg, P.Y.; Lordick, F.; Weis, J.; Faller, H.; Brähler, E.; Härter, M.; Wegscheider, K.; Geue, K.; Mehnert, A. Age and gender differences in anxiety and depression in cancer patients compared with the general population. Eur. J. Cancer Care 2019, 28, e13129. [Google Scholar] [CrossRef]
- Wang, C.; Yan, J.; Chen, J.; Wang, Y.; Lin, Y.C.; Hu, R.; Wu, Y. Factors associated with quality of life of adult patients with acute leukemia and their family caregivers in China: A cross-sectional study. Health Qual. Life Outcomes 2020, 18, 8. [Google Scholar] [CrossRef]
- Ivziku, D.; Clari, M.; Piredda, M.; De Marinis, M.G.; Matarese, M. Anxiety, depression and quality of life in chronic obstructive pulmonary disease patients and caregivers: An actor-partner interdependence model analysis. Qual. Life Res. Int. J. Qual. Life Asp. Treat. Care Rehabil. 2019, 28, 461–472. [Google Scholar] [CrossRef]
- Kim, Y.; Carver, C.S.; Spillers, R.L.; Crammer, C.; Zhou, E.S. Individual and dyadic relations between spiritual well-being and quality of life among cancer survivors and their spousal caregivers. Psycho-Oncology 2011, 20, 762–770. [Google Scholar] [CrossRef]
- Bixia, Z.; Xiao, J.; Xiaolin, K.; Biyu, S.; Ding-Rong, Q.; Jinrui, P.; Erhui, C.; Xiping, D.; Xiaoling, C.; Cho Lee, W. Effects of a Virtual Reality-Based Meditation Intervention on Anxiety and Depression Among Patients With Acute Leukemia During Induction Chemotherapy: A Randomized Controlled Trial. Cancer Nurs. 2023, 47, E159–E167. [Google Scholar] [CrossRef]
- Anna, W.; Ewa, W.; Krzysztof, K. Mental state and its psychophysical conditions in patients with acute leukaemia treated with bone marrow transplantation. Psychiatr. Danub. 2015, 27, 415–422. [Google Scholar]
- Anna, W.; Irena, K.-M.; Krzysztof, K. Anxiety and depression in patients with acute leukaemia treated with hematopoietic stem cell transplantation. Psychiatr. Danub. 2019, 31, 231–236. [Google Scholar]
Characteristics | N | % | |
---|---|---|---|
Gender | Male | 44 | 53.7% |
Female | 38 | 46.3% | |
Living location | Urban | 25 | 30.5% |
Rural | 57 | 69.5% | |
Education | Elementary | 8 | 9.8% |
Secondary | 16 | 19.5% | |
High school | 37 | 45.1% | |
Undergraduate or above | 21 | 25.6% | |
Occupation | Students | 5 | 6.1% |
Farmer | 24 | 29.3% | |
Blue-collar worker | 3 | 3.7% | |
Business | 16 | 19.5% | |
White-collar worker | 17 | 20.7% | |
Others | 17 | 20.7% | |
Marital status | Married | 68 | 82.9% |
Single/widow/divorce | 14 | 17.1% | |
Household monthly income (VND) | <5 mil/month | 31 | 37.8% |
5–10 mil/month | 26 | 31.7% | |
>10–20 mil/month | 18 | 22.0% | |
>20 mil/month | 7 | 8.5% | |
Duration of diseases (months) | ≤6 | 56 | 68.3% |
7–12 | 12 | 14.6% | |
>12 | 14 | 17.1% | |
Comorbidity | None | 62 | 75.6% |
Heart-related diseases | 7 | 8.5% | |
Respiratory disease | 3 | 3.7% | |
Digestive diseases | 12 | 14.6% | |
Endocrine disease | 3 | 3.7% | |
Musculoskeletal diseases | 3 | 3.7% | |
Others | 4 | 4.9% | |
Substance use | Smoking | 22 | 26.8% |
Smoking pipe tobacco | 6 | 7.3% | |
Drinking alcohol | 20 | 24.4% | |
Type of acute leukemia | Acute myeloid leukemia | 63 | 76.8% |
Acute lymphoblastic leukemia | 19 | 23.2% | |
Stage of treatment | Induction | 41 | 50.0% |
Consolidation | 10 | 12.2% | |
Relapse | 3 | 3.7% | |
Maintenance | 8 | 9.8% | |
None | 20 | 24.4% | |
Treatment | Chemical regime | 62 | 75.6% |
Supportive regime | 20 | 24.4% | |
Mean | SD | ||
Onset age (years) | 42.5 | 14.2 | |
Age (years) | 43.4 | 14.0 |
Having Depression (No = 0; Yes = 1) | BDI Depression Score | Having Anxiety (No = 0; Yes = 1) | Zung SAS Anxiety Score | |||||
---|---|---|---|---|---|---|---|---|
OR | 95%CI | Coef. | 95%CI | OR | 95%CI | Coef. | 95%CI | |
Age (per year) | 0.96 | 0.91; 1.01 | ||||||
Gender (female vs. male—ref) | 3.80 * | 1.21; 11.93 | 4.07 * | 1.64; 6.51 | ||||
Education (vs. <high school—ref) | ||||||||
High school | 0.32 | 0.07; 1.57 | −3.89 | −9.01; 1.23 | ||||
>High school | 7.32 * | 1.01; 53.23 | 3.49 | −2.64; 9.62 | ||||
Household monthly income (vs. <5 mil/month) | ||||||||
5–10 mil/month | 0.28 | 0.06; 1.32 | −2.61 | −7.85; 2.63 | 0.69 | 0.19; 2.54 | −0.84 | −3.68; 2.00 |
>10 mil/month | 0.06 * | 0.01; 0.44 | −6.05 * | −11.65; −0.46 | 0.28 | 0.07; 1.11 | −3.74 * | −6.57; −0.91 |
Marital status (having spouse vs. single/widow—ref) | 25.10 * | 2.14; 294.55 | 4.41 | −0.73; 9.55 | 4.21 * | 1.00; 7.41 | ||
Having any comorbidity (yes vs. no—ref) | 8.05 * | 1.63; 39.68 | 6.74 * | 2.07; 11.41 | ||||
Stage of treatment (vs. none—ref) | ||||||||
Consolidation | 0.49 | −3.61; 4.59 | ||||||
Induction | 2.63 | −0.23; 5.50 | ||||||
Others | 3.63 | −0.34; 7.61 | ||||||
Duration of disease (vs. ≤6 months—ref) | ||||||||
7–12 months | 0.24 | 0.04; 1.40 | ||||||
>12 months | 2.84 | 0.54; 14.85 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
An, T.T.H.; Van, N.T.; Tam, D.M.; Tai, N.T.; Hien, P.T.T.; Huong, P.L.; Lan, V.T.; Ngoc, P.T.M. Rates and Determinants of Depression and Anxiety Among Acute Leukemia Patients. Psychiatry Int. 2025, 6, 63. https://doi.org/10.3390/psychiatryint6020063
An TTH, Van NT, Tam DM, Tai NT, Hien PTT, Huong PL, Lan VT, Ngoc PTM. Rates and Determinants of Depression and Anxiety Among Acute Leukemia Patients. Psychiatry International. 2025; 6(2):63. https://doi.org/10.3390/psychiatryint6020063
Chicago/Turabian StyleAn, Tran Thi Ha, Nguyen Thao Van, Duong Minh Tam, Nguyen The Tai, Pham Thi Thu Hien, Pham Lien Huong, Vu Thi Lan, and Phan Thi Minh Ngoc. 2025. "Rates and Determinants of Depression and Anxiety Among Acute Leukemia Patients" Psychiatry International 6, no. 2: 63. https://doi.org/10.3390/psychiatryint6020063
APA StyleAn, T. T. H., Van, N. T., Tam, D. M., Tai, N. T., Hien, P. T. T., Huong, P. L., Lan, V. T., & Ngoc, P. T. M. (2025). Rates and Determinants of Depression and Anxiety Among Acute Leukemia Patients. Psychiatry International, 6(2), 63. https://doi.org/10.3390/psychiatryint6020063